Danimer Scientific, Inc.
DelistedCIK 1779020fmd_1V5PFX7C2PEVYS5HXQ2VMH9W74Manufacturing · Plastic Materials, Synth Resins & Nonvulcan ElastomersTemplate: Standard
Coverage: Jan 01, 2019 to Sep 30, 2024, 20 periods
| Line item | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 |
|---|---|---|---|---|---|
| Total revenues | 32 | 47 | 59 | 53 | 47 |
| Cost of revenue | 21 | 36 | 58 | 64 | 74 |
| Net interest income | (3) | (2) | (1) | (2) | (30) |
| Gross profit | 11 | 11 | 1 | (10) | (27) |
| Research and development | 5 | 8 | 20 | 32 | 29 |
| Selling, general and administrative | 16 | 19 | 80 | 82 | 69 |
| Operating income | (18) | (16) | (99) | (187) | (126) |
| Interest expense | 3 | 2 | – | – | – |
| Other non-operating income (expense) | 3 | 7 | 26 | 7 | (30) |
| Income before taxes | (15) | (9) | (73) | (181) | (155) |
| Income tax expense | 4 | 0 | (13) | (1) | 0 |
| Net income from continuing operations | (20) | (9) | (60) | (180) | (155) |
| Net income | (20) | (9) | (60) | (180) | (155) |